PATENT CLAIM ANALYSIS

Application Number: 16208696
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["548", "251000"]

Abstract:
The present invention relates to a process for preparing amorphous form of Sacubitril/Valsartan sodium salt of Formula-II and pharmaceutical composition comprising thereof.

Claim (Index 2):
Stable Amorphous form of Sacubitril/Valsartan sodium salt having water content in the range of 2% to 7% w/w; preferably 2% to 6% w/w; more preferably 2.5% to 4% w/w and sodium content in the range of 6% to 9% w/w.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 98.0
- Lexical Diversity: 1.04545
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15752943', '15568550', '16046531', '15735717', '16060297']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7311775029030989
- 35 USC 102 Novelty (BERT): 0.5424533711124974
- Combined Prediction Score: 0.7123050897240388
- Mean Citation Score: 292.73433
- Max Citation Score: 377.18597
- Similarity Product: 218.846026343354

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test